ReWalk Robotics Ltd.
Latest From ReWalk Robotics Ltd.
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week’s approvals include the US FDA's approval of a panel-track supplement for TransMedics' OCS Lung system to preserve donor lungs that would not be salvageable using a traditional cold static system.
Israel-based exoskeleton company ReWalk Robotics Ltd. announced it received a CE mark for its next-gen ReStore Exo-Suit for stroke rehabilitation, paving the way into a larger patient population.
When it comes to helping patients recover from spinal cord injuries and stroke, the use of exoskeletons – a robotic suit that supports a person's weight and helps them move their limbs – is gaining traction by physical therapists in rehabilitation centers and clinical settings. Several exoskeleton companies such as ReWalk, Ekso Bionics and Parker Hannifin are already marketing their own versions of these smart, robotic-assisted body suits in various countries worldwide. Despite facing significant barriers, such as high device cost and lack of reimbursement, recent advances in robotics, microelectronics, battery technologies and product designs are the driving forces behind the continuous innovation in this field. Companies hope the dramatic life-changing impact exoskeletons have today in helping the paralyzed will also have implications for other mobility-challenged individuals, including those living with Parkinson's disease, multiple sclerosis, cerebral palsy and the elderly.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance or Financing. This month’s column covers deals announced in November 2017.
- Rehabilitation Equipment and Devices
- Therapeutic Areas
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Argo Medical Technologies
- Middle East
- Parent & Subsidiaries
- ReWalk Robotics Ltd.
- Senior Management
Larry Jasinski, CEO
Ori Gon, CFO
Ofir Koren, VP, R&D & Regulatory
- Contact Info
ReWalk Robotics Ltd.
Phone: 4 959 0123
3 Hatnufa St., Fl. 6
P.O. Box 161 Yokneam , 2069203
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.